12:00 AM
Mar 22, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Neotrofin leteprinim (AIT-082): Expanded Phase IIb trial

NeoTherapeutics Inc. (NEOT), Irvine, Calif.
Product: Neotrofin leteprinim (AIT-082)
Business: Neurological
Therapeutic category: Growth factor, Nerve...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >